California State Teachers Retirement System lifted its holdings in shares of Humana Inc (NYSE:HUM) by 5.7% in the fourth quarter, Holdings Channel reports. The institutional investor owned 261,949 shares of the insurance provider’s stock after buying an additional 14,201 shares during the period. California State Teachers Retirement System’s holdings in Humana were worth $64,982,000 as of its most recent SEC filing.
Several other institutional investors have also bought and sold shares of HUM. Fieldpoint Private Securities LLC acquired a new stake in Humana in the 3rd quarter valued at about $115,000. American Beacon Advisors Inc. acquired a new stake in Humana in the 4th quarter valued at about $122,000. ClariVest Asset Management LLC acquired a new stake in Humana in the 3rd quarter valued at about $144,000. YorkBridge Wealth Partners LLC lifted its stake in Humana by 99.0% in the 4th quarter. YorkBridge Wealth Partners LLC now owns 597 shares of the insurance provider’s stock valued at $159,000 after purchasing an additional 297 shares during the last quarter. Finally, Daiwa SB Investments Ltd. lifted its stake in Humana by 44.9% in the 4th quarter. Daiwa SB Investments Ltd. now owns 710 shares of the insurance provider’s stock valued at $176,000 after purchasing an additional 220 shares during the last quarter. Institutional investors own 97.85% of the company’s stock.
In other news, VP Timothy S. Huval sold 1,382 shares of the firm’s stock in a transaction that occurred on Tuesday, December 19th. The shares were sold at an average price of $246.04, for a total transaction of $340,027.28. Following the transaction, the vice president now directly owns 11,557 shares of the company’s stock, valued at $2,843,484.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Brian P. Leclaire sold 1,679 shares of the firm’s stock in a transaction that occurred on Thursday, December 21st. The stock was sold at an average price of $245.97, for a total transaction of $412,983.63. Following the transaction, the senior vice president now directly owns 9,888 shares in the company, valued at $2,432,151.36. The disclosure for this sale can be found here. Insiders have sold 41,775 shares of company stock worth $11,169,845 over the last ninety days. Insiders own 0.60% of the company’s stock.
Several brokerages recently issued reports on HUM. Zacks Investment Research downgraded shares of Humana from a “buy” rating to a “hold” rating in a research note on Tuesday. JPMorgan Chase & Co. raised their target price on shares of Humana from $253.00 to $271.00 and gave the company a “neutral” rating in a research note on Monday, February 12th. Oppenheimer raised their target price on shares of Humana from $275.00 to $305.00 and gave the company an “outperform” rating in a research note on Thursday, February 8th. Cantor Fitzgerald reiterated a “hold” rating and issued a $250.00 target price on shares of Humana in a research note on Wednesday, February 7th. Finally, Leerink Swann raised their target price on shares of Humana from $280.00 to $300.00 and gave the company an “outperform” rating in a research note on Thursday, February 8th. Eight investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Humana has an average rating of “Buy” and an average price target of $270.47.
Shares of Humana Inc (NYSE:HUM) opened at $269.98 on Wednesday. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.48. The stock has a market cap of $37,170.00, a P/E ratio of 15.33, a price-to-earnings-growth ratio of 1.48 and a beta of 0.95. Humana Inc has a 1 year low of $203.48 and a 1 year high of $293.35.
Humana (NYSE:HUM) last announced its earnings results on Wednesday, February 7th. The insurance provider reported $2.06 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.00 by $0.06. Humana had a net margin of 4.55% and a return on equity of 16.13%. The company had revenue of $13.19 billion for the quarter, compared to analysts’ expectations of $13.14 billion. During the same period last year, the firm earned $2.34 earnings per share. The business’s revenue for the quarter was up 2.4% on a year-over-year basis. sell-side analysts anticipate that Humana Inc will post 13.81 EPS for the current fiscal year.
Humana declared that its Board of Directors has approved a stock buyback program on Thursday, December 14th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the insurance provider to purchase shares of its stock through open market purchases. Shares buyback programs are typically a sign that the company’s management believes its shares are undervalued.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, March 30th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, March 28th. This is a boost from Humana’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a dividend yield of 0.74%. Humana’s dividend payout ratio (DPR) is currently 9.09%.
TRADEMARK VIOLATION NOTICE: “California State Teachers Retirement System Acquires 14,201 Shares of Humana Inc (HUM)” was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this article on another site, it was illegally copied and republished in violation of US and international copyright and trademark law. The correct version of this article can be viewed at https://ledgergazette.com/2018/03/14/california-state-teachers-retirement-system-acquires-14201-shares-of-humana-inc-hum.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.